Morgan Stanley’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Morgan Stanley’s Portfolio SHACU Stock Details SHACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-401	Closed	-$4K	–	8076
2022 Q3	$4K	Sell	401 -3,000	-88%	-$29.6K	﹤0.01%	7357
2022 Q2	$33K	Sell	3,401 -2,626	-44%	-$25.9K	﹤0.01%	6809
2022 Q1	$59K	Hold	6,027	–	–	﹤0.01%	6632
2021 Q4	$61K	Hold	6,027	–	–	﹤0.01%	6725
2021 Q3	$60K	Hold	6,027	–	–	﹤0.01%	6638
2021 Q2	$61K	Hold	6,027	–	–	﹤0.01%	6591
2021 Q1	$60K	Buy	+6,027	New	+$61.4K	﹤0.01%	6276

Morgan Stanley's SHACU Position: Q4 2022 in Review

Morgan Stanley sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q4 2022, closing a stake of 401 shares — an estimated $4K sold.

Morgan Stanley first reported a position in SHACU in Q1 2021 and held it in 7 quarters. The position peaked at $61K in Q4 2021. 0 funds tracked by Wall St. Rank hold SHACU as of Q4 2022.

Morgan Stanley reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q4 2022 after selling out during the quarter.
Morgan Stanley sold 401 SCP & CO Healthcare Acquisition Company Unit shares in Q4 2022, an estimated $4K.
Morgan Stanley first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 7 quarters.
Morgan Stanley's SCP & CO Healthcare Acquisition Company Unit position peaked at $61K in Q4 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.